Panbela Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Panbela Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2023.
  • Panbela Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $26.3M, a 20.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $26.3M +$4.5M +20.6% Dec 31, 2023 10-K 2024-03-26
Q4 2022 $21.8M +$9.8M +81.5% Dec 31, 2022 10-K 2024-03-26
Q4 2021 $12M +$2.56M +27% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $9.46M +$1.62M +20.6% Dec 31, 2020 10-K 2022-03-24
Q4 2019 $7.84M +$2.04M +35.2% Dec 31, 2019 10-K 2021-03-25
Q4 2018 $5.8M +$1.72M +42.2% Dec 31, 2018 10-K 2020-03-24
Q4 2017 $4.08M -$393K -8.79% Dec 31, 2017 10-K 2019-03-22
Q4 2016 $4.47M +$661K +17.3% Dec 31, 2016 10-K 2018-03-21
Q4 2015 $3.81M +$1.19M +45.5% Dec 31, 2015 10-K 2017-03-30
Q4 2014 $2.62M +$6.98M Dec 31, 2014 10-K 2016-03-08
Q4 2013 -$4.36M -$50.2K -1.17% Dec 31, 2013 10-K 2015-03-30
Q4 2012 -$4.31M Dec 31, 2012 10-K 2014-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.